![Pharmacokinetic Study of Raltegravir in HIV-Infected Patients With End-Stage Liver Disease: The LIVERAL-ANRS 148 Study]()
Pharmacokinetic Study of Raltegravir in HIV-Infected Patients With End-Stage Liver Disease: The LIVERAL-ANRS 148 StudyBarau, C.; Braun, J.; Vincent, C.; Haim-Boukobza, S.; Molina, J.-M.; Miailhes, P.; Fournier, I.; Aboulker, J.-P.; Vittecoq, D.; Duclos-Vallee, J.-C.; Taburet, A.-M.; Teicher, E.; Teicher, E.; Duclos-Vallee, J.-C.; Aboulker, J.-P.; Braun, J.; Fournier, I.; Vincent, C.; Arulananthan, A.; Eliette, V.; Euphrasie, F.; Guillon, B.; Ralaimazava, P.; Haim-Boukobza, S.; Roque-Afonso, A.-M.; Bonhomme-Faivre, L.; Rudant, E.; Taburet, A.-M.; Aboulker, J. P.; Bonhomme-Faivre, L.; Braun, J.; Couffin-Cadiergues, S.; Delaugerre, C.; Durand, F.; Vittecoq, D.; Flandre, P.; Garraffo, R.; Ghosn, J.; Marraud, A.; Pageaux, G.; Derradji, O.; Bolliot, C.; Churaqui, F.; Antonini, T. M.; Coilly, A.; Ichai, P.; Ogier, O.; Belnard, M.; Molina, J.-M.; De Lastours, V.; Gazaignes, S.; Ponscarme, D.; Sauvageon, H.; Miailhes, P.; Koffi, J.; Radenne, S.; Brochier, C. · Clinical Infectious Diseases · 2014